Twist Bioscience stock gains momentum with strong buying as bullish trend accelerates

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience jumps 6.86% today

Highlights

TWST maintains strong bullish momentum, with price consolidating above medium- and long-term support and testing resistance near 94.10.
Next week's projected trading range is 85.00 to 105.00, with buyers dominating and upside favored by technical signals.
Multiple overbought indicators and mild short-term exhaustion suggest potential for a pause or pullback despite the prevailing uptrend.

The company encouraged NGS fans, biotech experts, antibody specialists, virologists, researchers, and scientists to read the newsletter for more details.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Medium- and long-term strength as Ichimoku resistance caps gains

TWST is trading at $91.33, just below the MA-20 ($91.83), well above the MA-50 ($82.67), and significantly above the MA-200 ($52.28), signaling strong medium- and long-term bullish momentum but mild short-term resistance. The Ichimoku Kijun sits at $94.10, now acting as immediate resistance. Near-term support is seen at MA-50 ($82.67), with key support at MA-100 ($67.46). Immediate resistance is the Ichimoku Kijun ($94.10), with key resistance at the 52-week high ($105.41).

Robust momentum with intraday buyers as overbought signals emerge

Momentum indicators on D1 are robust, with MACD showing a strong buy and ADX at 26.93, confirming a healthy trend. RSI sits at 52.94, indicating mild bullish bias, while Stoch RSI flags a strong buy but nears overbought territory. CCI, however, shows a sell signal, suggesting possible short-term exhaustion. BBP registers as overbought, highlighting ongoing buyer dominance, supported by intraday momentum. The Awesome Oscillator reads neutral and does not reinforce the active trend. TWST is trading at $91.33, up from the previous weekly close of $90.27, reflecting a 1.17% gain. The price sits in the upper part of the weekly range, with weekly volatility at 15.11%, and action shows a recovery from the weekly low. In today's session, the stock is up 6.86% with strong intraday momentum and aggressive buying pressure.

Upside favored as overbought risk tempers bullish outlook

Looking ahead, the expected price range for the next week is $85.00 to $105.00, kept within ±20% of the current price and in line with its position between the 52-week low ($23.30) and high ($105.41). All major weekly indicators (MA-50, RSI, ADX, and MACD) on W1 flash Buy, giving a very high probability (more than 80%) for further price gains next week, with a low chance of a reversal. The baseline scenario sees price consolidation between the $85.00 support and the $94.10–$105.00 resistance levels. A bullish scenario could trigger if price breaks above $94.10, targeting the $100.00–$105.00 zone. A bearish scenario may develop only if support at $85.00 fails, opening room for a retest of MA-50 support in the low $80s. Overall, the technical backdrop heavily favors continued upside, but overbought signals warrant close monitoring for a potential pause or pullback.

Earlier, analysts noted that Twist Bioscience maintained a bullish long-term outlook despite short-term technical pressures and volatility. The current analysis adds depth by emphasizing the importance of monitoring ongoing momentum shifts, with particular attention now on the sustainability of buyer interest as a potential catalyst for the next directional move.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.